Menu Back toDIA Medical Affairs forum 2021 in Japan

DIA Medical Affairs forum 2021 in Japan

All prices are exclusive of 10% Japanese consumption tax

Overview

Click Here to View the Program in Japanese

The WEB registration has been closed. Please contact DIA Japan if you want to Join the Forum.

Program Committee

  • Shinichi Nishiuma, MD
    Shinichi Nishiuma, MD • Head of Oncology Medical Science, Japan medical
    BMS, Japan
  • Tadashi Urashima, PhD
    Tadashi Urashima, PhD • Performance and Digital Analytics Lead, Medical & Development Excellence Japan
    GlaxoSmithKline K.K., Japan
  • Takeshi Ishido
    Takeshi Ishido • Sr Manager, Medical Contetn, Medical Excellence
    Bristol-Myers Squibb.K.K. , Japan
  • Sonoko Misawa, MD, PhD
    Sonoko Misawa, MD, PhD • Associate Professor
    Chiba University, Japan
  • Hideki Ninomiya, MD
    Hideki Ninomiya, MD • CEO
    Datack Inc, Japan
  • Yoshiyuki Sugimoto
    Yoshiyuki Sugimoto • Medical Manager
    Sanofi K.K., Japan
  • Mitsutoshi Toda, MBA
    Mitsutoshi Toda, MBA • Group Manager, CRM Medical Franchise Dept. Japan Medical Division
    Novartis Pharma K.K., Japan
  • Shuji Uno, PhD
    Shuji Uno, PhD • Medical Lead, Hematology, Japan Medical
    Bristol-Myers Squibb K.K., Japan
  • Tetsuya Watanabe, RPh
    Tetsuya Watanabe, RPh • Senior Medical Director, Medical Affairs
    Astellas Pharma Inc., Japan
Load More